Management for Stroke
Know the exclusion criteria for thrombolytic therapy - Cynthia Leung MD PhD
image by: Rebel EM
HWN Recommends
Stroke me, Code Stroke me
tPA: Let’s talk about the elephant in the room, does it work or not... It is estimated that 2-5% of all strokes will get tPA. Alteplase is first-line therapy, dosed at 0.9/mg/kg. You must confirm the following prior to tPA administration: persistent neurologic deficit on exam that is considered disabling (i.e. prevents basic daily life functions), serum glucose is normal, BP goals are met, >1 large-bore IV line is present, all eligibility criteria are met. 10% of the dose is given over 1 minute as a bolus and the rest is given over one hour.
What about those with an unwitnessed stroke or the “wake-up” stroke >4.5 hours symptom onset? There is mixed data, but promising,…
Resources
ED Stroke Management in the Age of Endovascular Therapy
Activating a “code stroke” on every patient that experiences any acute neurologic event within 24hrs of symptom onset based on the DIFFUSE 3 and DAWN trials [2,3] may outstrip resources, with only a tiny minority of these patients receiving potential benefit. There is currently an effort to identify those patients clinically who might be most likely to benefit from endovascular therapy so that not all stroke patients require transport to a stroke center with multiple imaging modalities and resource-heavy acute stroke team care.
Thrombolytics for stroke: The evidence
Thrombolytics for stroke: undoubtedly the biggest controversy in emergency medicine.
Time is Brain – Acute Ischemic Stroke Part 2: Mechanical Thrombectomy
Mechanical thrombectomy has revolutionized stroke care for patients with large vessel occlusions (LVOs). LVOs account for ~40% of all AIS, and prior to endovascular therapy more than half of these patients suffered significant post-stroke disability (modified Rankin Scale (mRS) 4-5) or death (mRS 6). This post reviews who qualifies for mechanical thrombectomy, the process of screening, and how the field of interventional neurology continues to evolve.
Time is Brain – Acute Ischemic Stroke Part I: Vascular Syndromes and Thrombolysis
About ~800K people have a stroke in the US every year (1 person every 40 seconds) and stroke is a leading cause of serious long-term disability (PMID: 31992061). But prior to ~2015, outside of trials, the acute ischemic stroke patient either arrived within 4.5 hours and got tPA or they got supportive care. And, unfortunately, very few patients arrive within the 4.5 hour time window. Things are dramatically different now. The endovascular era in stroke care has revolutionized care for patients with large vessel occlusions (LVO) – which is the subgroup of patients that before the reperfusion era accounted for the highest stroke morbidity and mortality. There is now effective treatment for those who present within 24 hours.
Should we Consider Endovascular Therapy for Acute Basilar Artery Occlusion?
In patients with acute basilar artery occlusion is favorable functional outcome at 90 days improved with endovascular therapy vs standard medical care?
Stroke Care: A Balanced Approach to tPA
The question of the safety and efficacy of alteplase (tPA) for the treatment of acute ischemic stroke (AIS) has been debated by emergency physicians (EPs) for many years.
Stroke me, Code Stroke me
The immediate goal of stroke assessment in the ED is to minimize brain injury and treat medical complications. At the same time, you must have an open mind and large differential as there are a great number of stroke mimickers.
NIH Stroke Scale
0 Normal, 1-4 Minor, 5-15 Moderate, 15-20 Moderately Severe, > 20 Severe
Critical Care Medicine
The primary goal of advanced stroke management is revascularization and limitation of secondary neuronal injury. IV thrombolysis and EVT are now available for selected patients.
CDEM
The single most important component of the history is the exact time of onset of symptoms. This is defined as the time when the patient was last known to be symptom-free, commonly referred to as the “last known well”.
Update on Management of Acute Ischemic Stroke in The Emergency Department
In patients who are not candidate for reperfusion therapy, the blood pressure should not be treated acutely unless the hypertension is extreme (SBP>220 or DBP>120 mmHg), or the patient has active ischemic coronary disease, heart failure, aortic dissection, hypertensive encephalopathy, or pre-eclampsia/eclampsia. When treatment is indicated, cautious lowering of blood pressure by approximately 15% during the first 24 hours after stroke onset is suggested.
Introducing Stitches!
Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!
Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.
